This trial is looking at a drug called Spironolactone to see whether it helps reduce heart disease and kidney damage in people with chronic kidney disease.

The trial is currently in the long term follow up stage of recruited participants.

The results of this research trial will be published in a scientific medical journal and on the study website.

Thank you to the 9 patients from BMG who have taken part in Barack-D.